Three pharmaceutical companies on Tuesday added another patent to an infringement suit against Sandoz Inc., as it tries to prevent a contingent of drugmakers from bringing generic versions of the gastrointestinal drug Linzess to market. In an eight-page complaint, Allergan USA, Forest Laboratories …
